Pathfinders in Biopharma

PTC Therapeutics: Building a durable company to benefit patients


Listen Later

A surgeon in burns reconstruction, Matt Klein swapped the operating room for the equally high-pressure environment of drug development. In this episode of Pathfinders in Biopharma, he sets out the vision for the company he now leads, PTC Therapeutics – a pioneer in the field of RNA therapies, now powering towards profitability with treatment candidates for a host of rare diseases.

...more
View all episodesView all episodes
Download on the App Store

Pathfinders in BiopharmaBy RBC Capital Markets

  • 5
  • 5
  • 5
  • 5
  • 5

5

12 ratings


More shows like Pathfinders in Biopharma

View all
Motley Fool Money by The Motley Fool

Motley Fool Money

3,227 Listeners

WSJ Your Money Briefing by The Wall Street Journal

WSJ Your Money Briefing

1,731 Listeners

Exchanges by Goldman Sachs

Exchanges

977 Listeners

Odd Lots by Bloomberg

Odd Lots

1,989 Listeners

WSJ Tech News Briefing by The Wall Street Journal

WSJ Tech News Briefing

1,654 Listeners

The a16z Show by Andreessen Horowitz

The a16z Show

1,096 Listeners

The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

126 Listeners

The Readout Loud by STAT

The Readout Loud

337 Listeners

Wall Street Breakfast by Seeking Alpha

Wall Street Breakfast

1,043 Listeners

Thoughts on the Market by Morgan Stanley

Thoughts on the Market

1,316 Listeners

The Journal. by The Wall Street Journal & Spotify Studios

The Journal.

6,131 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

34 Listeners

RBC's Markets in Motion by RBC Capital Markets

RBC's Markets in Motion

40 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

Biotech Hangout

21 Listeners

Industries in Motion by RBC Capital Markets

Industries in Motion

10 Listeners

Powering Sustainable Ideas by RBC Capital Markets

Powering Sustainable Ideas

0 Listeners

The Markets by Goldman Sachs

The Markets

86 Listeners

Strategic Alternatives by RBC Capital Markets

Strategic Alternatives

18 Listeners

The Top Line by Fierce Life Sciences

The Top Line

15 Listeners

Macro Minutes by RBC Capital Markets

Macro Minutes

3 Listeners